<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">21997336</PMID>
        <DateCompleted>
            <Year>2012</Year>
            <Month>02</Month>
            <Day>29</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>12</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1557-1904</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>6</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</Title>
                <ISOAbbreviation>J Neuroimmune Pharmacol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Drugs of abuse effects on immunity and microbial pathogenesis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>435-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11481-011-9318-z</ELocationID>
            <Abstract>
                <AbstractText>Substance abuse remains a serious medical, public health, and social problem. The impact on destructive public health and health costs compounded with the negative consequences of drugs abuse poses a significant toll on the economy. Despite significant advancement of research in the field treatment of and care of patients with substance abuse has lagged behind because of limited education and training of clinicians on substance abuse problems. The goal of the special issue is to provide the current status on the mechanisms underlying the increased prevalence of opportunistic infections in the drug abuse population, to identify important areas where further research would be beneficial and to open new avenues of investigation for therapeutic development. We aimed these articles for the benefit of both basic and clinical researchers.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Roy</LastName>
                    <ForeName>Sabita</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, Division of Infection, Inflammation and Vascular Biology, University of Minnesota Medical Center, 420 Delaware Street SE, Mayo Mail Code 195, Minneapolis, MN 55455, USA. royxx002@umn.edu</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 DA012104</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 DA022935</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 DA031202</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>KO2 DA015349</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 DA12104</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P50 DA011806</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>K02 DA015349</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P50 DA11806</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D054711">Introductory Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2011</Year>
                <Month>10</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Neuroimmune Pharmacol</MedlineTA>
            <NlmUniqueID>101256586</NlmUniqueID>
            <ISSNLinking>1557-1890</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D013287">Illicit Drugs</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013287" MajorTopicYN="N">Illicit Drugs</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009894" MajorTopicYN="N">Opportunistic Infections</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010506" MajorTopicYN="Y">Periodicals as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2011</Year>
                <Month>09</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2011</Year>
                <Month>09</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2012</Year>
                <Month>3</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">21997336</ArticleId>
            <ArticleId IdType="doi">10.1007/s11481-011-9318-z</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2006 Mar;1(1):77-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18040793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):516-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21830069</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2010 Jun 1;50(11):1505-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20415569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):585-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21671006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):442-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21789507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):546-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21656184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 2011 May 23;88(21-22):931-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21219914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Drug Policy. 2009 Nov;20(6):475-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19356915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):566-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21735070</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):477-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21755286</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):466-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21465240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):608-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21938479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):597-607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21744004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):578-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21881858</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):503-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21766222</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 2011 May 23;88(21-22):972-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21056582</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):490-502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21728033</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Immunol Ther Exp (Warsz). 2008 Sep-Oct;56(5):299-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18836861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2004 Nov 19;18(17):2295-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15577542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Microbiol. 2011 Apr;60(Pt 4):408-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21389334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>HIV Med. 2012 Feb;13(2):89-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21819529</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurobiol. 2011 Aug;44(1):102-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21717292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2009 Jun 27;373(9682):2223-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19560604</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):540-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21484257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):528-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21850403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2011 Dec;6(4):551-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21826405</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
